Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma

Jutta Huvila, Teemu D. Laajala, Per-Henrik Edqvist, Adil Mardinoglu, Lauri Talve, Fredrik Ponten, Seija Grenman, Olli Carpen, Tero Aittokallio, Annika Auranen

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftGynecologic Oncology
Volym149
Utgåva1
Sidor (från-till)173-180
Antal sidor8
ISSN0090-8258
DOI
StatusPublicerad - apr 2018
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar
  • 3123 Kvinno- och barnsjukdomar

Citera det här

Huvila, Jutta ; Laajala, Teemu D. ; Edqvist, Per-Henrik ; Mardinoglu, Adil ; Talve, Lauri ; Ponten, Fredrik ; Grenman, Seija ; Carpen, Olli ; Aittokallio, Tero ; Auranen, Annika. / Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma. I: Gynecologic Oncology. 2018 ; Vol. 149, Nr. 1. s. 173-180.
@article{882cd1a4f9644ee8819bb13315393107,
title = "Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma",
keywords = "Endometrial cancer, Risk stratification, Prognostic, Modelling, ASRGL1, p53, L1CAM EXPRESSION, REGULARIZATION PATHS, COORDINATE DESCENT, CANCER, RISK, CLASSIFICATION, PROFILES, DISEASE, UTILITY, SYSTEM, 3122 Cancers, 3123 Gynaecology and paediatrics",
author = "Jutta Huvila and Laajala, {Teemu D.} and Per-Henrik Edqvist and Adil Mardinoglu and Lauri Talve and Fredrik Ponten and Seija Grenman and Olli Carpen and Tero Aittokallio and Annika Auranen",
year = "2018",
month = "4",
doi = "10.1016/j.ygyno.2018.02.016",
language = "English",
volume = "149",
pages = "173--180",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "1",

}

Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma. / Huvila, Jutta; Laajala, Teemu D.; Edqvist, Per-Henrik; Mardinoglu, Adil; Talve, Lauri; Ponten, Fredrik; Grenman, Seija; Carpen, Olli; Aittokallio, Tero; Auranen, Annika.

I: Gynecologic Oncology, Vol. 149, Nr. 1, 04.2018, s. 173-180.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

TY - JOUR

T1 - Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma

AU - Huvila, Jutta

AU - Laajala, Teemu D.

AU - Edqvist, Per-Henrik

AU - Mardinoglu, Adil

AU - Talve, Lauri

AU - Ponten, Fredrik

AU - Grenman, Seija

AU - Carpen, Olli

AU - Aittokallio, Tero

AU - Auranen, Annika

PY - 2018/4

Y1 - 2018/4

KW - Endometrial cancer

KW - Risk stratification

KW - Prognostic

KW - Modelling

KW - ASRGL1

KW - p53

KW - L1CAM EXPRESSION

KW - REGULARIZATION PATHS

KW - COORDINATE DESCENT

KW - CANCER

KW - RISK

KW - CLASSIFICATION

KW - PROFILES

KW - DISEASE

KW - UTILITY

KW - SYSTEM

KW - 3122 Cancers

KW - 3123 Gynaecology and paediatrics

U2 - 10.1016/j.ygyno.2018.02.016

DO - 10.1016/j.ygyno.2018.02.016

M3 - Article

VL - 149

SP - 173

EP - 180

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -